Why Sponsor?
Sponsoring the Scrip Awards is the most cost-effective way of consistently promoting your company to leaders in the biopharma industry. Your investment allows you the exclusive opportunity to meet face-to-face with key contacts, whilst reinforcing your brand positioning throughout the year. Demonstrate leadership and commitment to global healthcare by sponsoring these world-renowned and prestigious Awards. You will also benefit from a high-impact, multichannel marketing campaign, pre, during and post Awards.
KEY SPONSORSHIP BENEFITS
Network with key people within your industry
Take advantage of unrivalled brand promotion
Boost your competitive advantage
Position your company at the forefront of healthcare innovation
WHAT IS AVAILABLE TO SPONSOR
There are numerous sponsorship opportunities at the Scrip Awards including:
- Headline Sponsorship - SOLD
- Category Sponsorship*
- Drinks reception Sponsorship
- Social media Sponsorship
- Roundtable Sponsorship (exclusive and non-exclusive)
*Category Sponsorship will be on a first-come, first-served basis.
WHO WILL BE AT THE SCRIP AWARDS?
The Scrip Awards bring together over 400 key decision maker sand innovators to recognise outstanding achievements in the global biopharma industry.
Previous attendees include:
- AstraZeneca
- GSK
- ICON
- IQVIA
- Parexel
- MSD
- ROCHE
- Takeda
- WUXI AppTec
HOW WILL I BE PROMOTED AS A SPONSOR?
As a sponsor, benefit from these promotions and more, ensuring your company receives maximum exposure to the industry:
- Your company logo on all marketing collateral as sponsor
- Your company logo on all Scrip Awards adverts
- Company profile and logo on to the Scrip Awards 2024 website
- Social media announcements of your involvement
- Your company mentioned in Scrip Awards email campaigns
- Exclusive branded signage on the Awards night
- Adverts in the official Awards Programme and Guest List
HOW MUCH DOES IT COST TO SPONSOR
We’ll work to find the most suitable sponsorship package for you. If you have a query regarding sponsorship, please contact Casey Burwell at Email: casey.burwell@citeline.com for information.
KEY CEREMONY DETAILS
- Date: Wednesday, 4 December, 2024
- Location: Raffles London at the OWO
AM I ELIGIBLE TO SPONSOR?
There are a variety of sponsorship opportunities to suit you. If you have a query regarding sponsorship, please contact Casey Burwell at Email: casey.burwell@citeline.com for information.
PREVIOUS SCRIP AWARDS SPONSORS
Avance Clinical is a premium full-service Contract Research Organisation (CRO) based in Australia, New Zealand and North America, providing high-quality clinical research services to the international drug development industry which brings innovative new drugs to patients. Avance Clinical has more than 260 staff and has backing from the private equity group, Riverside Company, to support global expansion plans.
Avance Clinical offers clinical project management, trial monitoring, regulatory support, safety reporting, scientific and medical writing, data management, statistical and pharmacokinetic services, and external clinical auditing. We operate to the highest standards of compliance required by global regulatory agencies such as the FDA to ensure acceptance of data for drug approvals.
Our clients are international biotech companies in their early phases of drug development that require fast, agile, and adaptive solution-oriented clinical research services. The company uses state-of-the-art technology, gold standard systems, and deep scientific expertise to provide clients with the most successful outcomes.
The Avance Clinical team offers exceptional study approval and success rates which can be attributed to its deep scientific expertise, advanced data technologies, knowledge of the Australian, New Zealand and North American regulatory environment, and its extensive relationships with sites and KOLs.
Avance Clinical offers clinical project management, trial monitoring, regulatory support, safety reporting, scientific and medical writing, data management, statistical and pharmacokinetic services, and external clinical auditing. We operate to the highest standards of compliance required by global regulatory agencies such as the FDA to ensure acceptance of data for drug approvals.
Our clients are international biotech companies in their early phases of drug development that require fast, agile, and adaptive solution-oriented clinical research services. The company uses state-of-the-art technology, gold standard systems, and deep scientific expertise to provide clients with the most successful outcomes.
The Avance Clinical team offers exceptional study approval and success rates which can be attributed to its deep scientific expertise, advanced data technologies, knowledge of the Australian, New Zealand and North American regulatory environment, and its extensive relationships with sites and KOLs.
Clario generates the richest clinical evidence by fusing our deep scientific expertise and global scale into the broadest endpoint technology platform. By doing this, we empower our partners to transform lives.
ICON plc is a world-leading healthcare intelligence and clinical research organisation, with over 38,000 employees in 93 locations in 46 countries around the world, headquartered in Dublin. We advance clinical research by providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Our services span the entire lifecycle of product development, from molecule to medicine, across a broad range of therapeutic areas. We develop new innovations, drive emerging therapies forward, and improve patient lives.
IQVIA Consumer Health is a leading global provider of actionable insights, purpose-built technologies and exceptional market expertise to the consumer healthcare industry. IQVIA Consumer Health harnesses data from more than 80 countries to co-create and execute tailored initiatives for every stage of the concept-to-consumer journey. Utilizing IQVIA Connected Intelligence, we deliver specialized and actionable insights combining analytics, technology and domain expertise to help consumer healthcare organizations adapt and innovate fast to an ever-changing market, flawlessly navigate regulatory environments and engage effectively with customers and consumers.
MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From MSD’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. In 2019 MSD had sales of more than $46 billion and we operate in more than 140 countries.
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere.
Quris-AI is an artificial intelligence innovator that is disrupting the drug development process. Quris' Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. We are led by a team of top scientists and strategic investors and are actively preparing for clinical testing with our first AI-based drug.
We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization),helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2023 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey.
Leveraging our strong relationships, deep domain expertise, connected technology, and data intelligence we expand access, and enhance the quality, efficiency, and safety required to successfully advance research that saves and improves lives.
Leveraging our strong relationships, deep domain expertise, connected technology, and data intelligence we expand access, and enhance the quality, efficiency, and safety required to successfully advance research that saves and improves lives.
SPONSOR TESTIMONIALS
Parexel
Enquire about sponsoring